Thrombus Aspiration during Primary PCI Does Not Improve Clinical Outcomes

Thrombus Aspiration during Primary PCIThrombus aspiration during primary PCI in ST elevation MI has been extensively used; however, recent studies have questioned its efficacy and safety.

 

This meta-analysis looked into individual patient data to determine the benefit and safety of thrombus aspiration during primary PCI.

 

It included all randomized and controlled studies assessing manual thrombectomy vs. conventional primary PCI including more than 1.000 patients undergoing ST elevation MI. Individual patient data was provided by the lead researchers of each study.

 

Efficacy primary end point was cardiovascular mortality at 30 days and safety primary end point was any stroke or transient ischemic attack also at 30 days.

 

The 3 eligible studies (TAPAS, TASTE and TOTAL) enrolled 18,306 patients receiving primary PCI with available data.

 

Cardiovascular death at 30 days occurred in 221 patients (2.4%) out of 9,155 randomized to thrombectomy and in 262 (2.9%) of those randomized to primary PCI alone (HR: 0.84; CI 95%; p=0.06).

 

Stroke and transient ischemic attack occurred in 66 patients (0.8%) among those randomized to manual thrombectomy compared to 46 (0.5%) in the group of primary PCI alone (OR: 1.43 IC 0.98-2.1; p=0.06).

 

There were no significant differences in repeat MI rate, stent thrombosis, cardiac failure, or target vessel revascularization.

 

When studying the subgroup with high thrombotic load separately, thrombus aspiration was associated to lower cardiovascular death (2.5% vs. 3.1%, HR 0.80; p=0.03) but higher stroke or transient ischemic attack (0.9% vs. 0.5%, p=0.04). Despite these rates, the interaction p value was 0.32 and 0.34, respectively.

 

Conclusion

Routine thrombus aspiration during primary PCI does not improve clinical outcomes. In the subgroup of patients with high thrombotic load, there was a tendency to lower mortality and higher stroke rates, which provides the rationale for future studies.

 

Editorial Comment

The AHA/ACC 2015 guidelines state the use of thrombus aspiration in the context of primary PCI is IIb/C for cases with intra-luminal thrombus, and class III for routine use, in all cases. 

 

To date, the existing literature does not support the routine use of thrombus aspiration in the management of ST elevation acute myocardial infarction. Operators might consider the benefit of this technique is potentially higher than its risks on a case by case basis.

 

Original Title: Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.

Reference: Sanjit S. Jolly et al. Circulation 2016 Dec 9. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...